116 related articles for article (PubMed ID: 11201515)
1. Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells.
Seeger H; Wallwiener D; Mueck AO
Menopause; 2001; 8(1):5-9. PubMed ID: 11201515
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of tibolone and its metabolites on human vascular coronary cells.
Seeger H; Kloosterboer HJ; Studen M; Wallwiener D; Mueck AO
Maturitas; 2007 Sep; 58(1):42-9. PubMed ID: 17572028
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
Seeger H; Rakov V; Mueck AO
Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
[TBL] [Abstract][Full Text] [Related]
5. Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures.
Mueck AO; Seeger H; Wallwiener D
Menopause; 2002; 9(4):273-81. PubMed ID: 12082363
[TBL] [Abstract][Full Text] [Related]
6. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of progesterone, medroxyprogesterone acetate and norethisterone on the proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
J Br Menopause Soc; 2003 Mar; 9(1):36-8. PubMed ID: 12804312
[TBL] [Abstract][Full Text] [Related]
8. The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells.
Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
Menopause; 2005; 12(4):468-74. PubMed ID: 16037763
[TBL] [Abstract][Full Text] [Related]
9. [Effect of tibolone on vascular markers of human female coronary arteries - comparison with estradiol/norethisterone].
Mueck AO; Seeger H; Wallwiener D
Zentralbl Gynakol; 2001 Nov; 123(11):648-54. PubMed ID: 11797164
[TBL] [Abstract][Full Text] [Related]
10. The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Eur J Gynaecol Oncol; 2001; 22(5):331-5. PubMed ID: 11766732
[TBL] [Abstract][Full Text] [Related]
11. Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?
Mueck AO; Seeger H; Lippert TH
Clin Exp Obstet Gynecol; 1998; 25(1-2):26-8. PubMed ID: 9841134
[TBL] [Abstract][Full Text] [Related]
12. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
13. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO
Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641
[TBL] [Abstract][Full Text] [Related]
15. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
16. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B
Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
18. Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells.
Bhalla RC; Toth KF; Bhatty RA; Thompson LP; Sharma RV
Am J Physiol; 1997 Apr; 272(4 Pt 2):H1996-2003. PubMed ID: 9139988
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of continuous combined and sequential combined medroxyprogesterone acetate-estradiol treatment on the proliferation of MCF-7 cells.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Climacteric; 2000 Dec; 3(4):271-7. PubMed ID: 11910587
[TBL] [Abstract][Full Text] [Related]
20. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
